Endometrial cancer trials in China

In China 86 Also abroad 405

86 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
TR115 in ARID1A-Mutated Advanced Solid Tumors
Where
Shanghai
Age
18 years to 70 years
People
50
Run by
Tarapeutics Science Inc.
See details and how to joinNCT07793318
Phase 1/2Taking people
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Where
Anyang, Baoding, Beijing, Bengbu, Changchun, Changsha, Changzhou, Chongqing, Guangzhou, Hangzhou, Hefei, Hongcun, Jinan, Jining, Kunming, Lanzhou, Liaocheng, Nanchang, Nanning, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Wuxi, Xiamen, Xi’an, Xuzhou, Yantai, Yulin, Zhengzhou, Zibo
Age
18 years and over
People
796 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05150691
Phase 2Not yet taking people in China
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
Where
Changchun, Hangzhou, Shanghai, Tianjin, Wuhan, Zhengzhou
Age
18 years to 45 years
People
128
Run by
Tongji Hospital
See details and how to joinNCT07781150
No phaseTaking people
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Where
Beijing
Age
Up to 45 years
People
16
Run by
Peking University People's Hospital
See details and how to joinNCT06468215
Phase 1Taking people
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Where
Jinan
Age
18 years to 75 years
People
299 worldwide
Run by
Huahui Health
See details and how to joinNCT07623369
No phaseTaking people
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Where
Beijing
Age
18 years to 45 years
People
10
Run by
Peking University People's Hospital
See details and how to joinNCT06549855
Phase 2Not yet taking people in China
Elemene Liposomes in Endometrial Cancer
Where
Hangzhou
Age
18 years to 80 years
People
212
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT07738315
Phase 2Taking people
Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
Where
Hangzhou
Age
18 years to 75 years
People
39
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT06561308
Phase 3Taking people
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Xi'an, Zhanjiang, Zhengzhou
Age
18 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00
Phase 1Taking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Beijing, Shanghai
Age
18 years and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00
Phase 2Not yet taking people in China
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Where
Beijing
Age
Up to 46 years
People
48
Run by
Peking University People's Hospital
See details and how to joinNCT07714070
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
Where
Guangzhou
Age
18 years and over
People
178
Run by
Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT07610798
Phase 2Taking people
TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
Where
Shanghai
Age
18 years to 45 years
People
10
Run by
Fudan University
See details and how to joinNCT06914297
Phase 2/3Taking people
Trop2-targeted immunoPET Imaging of Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
RenJi Hospital
See details and how to joinNCT06851663
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
Where
Shanghai
Age
18 years and over
People
201
Run by
Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT07612891
No phaseTaking people
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07557225
Phase 2Taking people
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Where
Beijing
Age
18 years and over
People
220
Run by
Peking University People's Hospital
See details and how to joinNCT07586826
Phase 2Taking people
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Where
Jinan
Age
18 years to 80 years
People
30
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT06532539
Phase 2Taking people
Intrauterine Injection of Type III Collage in FST of EC/AEH
Where
Beijing
Age
18 years to 45 years
People
30
Run by
Wang Jianliu
See details and how to joinNCT07377734
Phase 2Taking people
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Where
Beijing, Changsha, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Jinan, Linyi, Nanjing, Shanghai, Shenyang, Tai’an, Tianjing, Wuhan, Yueyang, Zhengzhou
Age
18 years and over
People
108
Run by
3D Medicines (Sichuan) Co., Ltd.
See details and how to joinNCT05112991
Phase 2/3Taking people
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Where
Shanghai
Age
18 years to 45 years
People
260
Run by
Fudan University
See details and how to joinNCT07319429
Phase 1/2Taking people
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Where
Beijing, Hangzhou, Zhengzhou
Age
18 years and over
People
266
Run by
Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07371663
Phase 2Taking people
A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
Where
Shanghai
Age
18 years to 75 years
People
96
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07054567
Phase 1Taking people
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Where
Wuhan
Age
18 years and over
People
97
Run by
Tongji Hospital
See details and how to joinNCT06552598
Phase 1Taking people
A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
Where
Changchun, Jinan
Age
18 years and over
People
9
Run by
Shanghai Best-Link Bioscience, LLC
See details and how to joinNCT06738966